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Mouse modelsThe sex of an individual results from the paternal transmission of the SRY gene located on the Y chromosome.
In turn, SRY initiates Sox9 expression, a transcription factor required for testicular differentiation. Ectopic
activation of SOX9 in XX Wt1:Sox9 transgenic mice induces female-to-male sex reversal in adult mice. Here
we show that complete sex reversal is preceded by a transient phase of ovotestis differentiation with XXWt1:
Sox9 transgenic gonads containing a testicular central region and one or both ovarian poles indicating that
Wt1:Sox9 is not as efﬁcient as Sry to induce male development. In XXWt1:Sox9Tg/+ gonads, transgenic Sox9 is
expressed earlier than Sox9 in XY gonads and is able to induce the expression of EGFP, knocked into the 3′UTR
of Sox9 indicating that SOX9 is involved in the initiation andmaintenance of its own expression. However, the
delayed onset of expression of endogenous Sox9–EGFP suggests that this activation requires other factors,
whose expression depends on SOX9. In the testicular regions of the XX Wt1:Sox9 ovotestes, proliferation of
the XX fetal germ cells is hampered and they differentiate as pro-spermatogonia. This indicates that XX germ
cells are not competent to respond to proliferative signals released from a testicular environment. In the
ovarian regions, despite the continuous mRNA expression of theWT1:Sox9 transgene, the SOX9 protein does
not accumulate suggesting that regulation of this gene in ovarian cells involves post-transcriptional
mechanisms. Finally, ovarian cells of the XXWt1:Sox9 ovotestis undergo apoptosis during late embryogenesis
leading to complete female-to-male sex reversal of the transgenic mice at birth.R, INSERM U636, Université de
e. Fax: +33 492 07 64 02.
r).
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
In human and mice, paternal transmission of the Y chromosome
initiates sex determination. This is due to the expression of the SRY/Sry
gene located on this chromosome and whose expression promotes
testis differentiation of the bipotential gonad (Gubbay et al., 1990;
Sinclair et al., 1990). In the absence of SRY, the XX bipotential gonad
develops as an ovary. At a molecular level, this requires the activation
of the Wnt/β-catenin signaling pathway by the secreted protein
RSPO1 (Chassot et al., 2008; Parma et al., 2006). These ﬁrst steps
trigger complex molecular pathways leading to sexual differentiation
(for review, see Sekido and Lovell-Badge, 2009).
In mouse gonads, SRY speciﬁes the fate of the gonad in synergy
with SF1. Whereas Sf1 is expressed in the XX and XY bipotential
gonad, the expression of Sry is initiated in the precursor cells of the
supporting cell lineage in the center of the XY gonad (Bullejos andKoopman, 2001; Sekido et al., 2004; Wilhelm et al., 2005). Within the
next few hours, Sry expression extends to the anterior and then the
posterior poles. Although its expression commences at E10.5, SRY
becomes only functional between E11.0–11.25 and expression ceases
at E12.5 (Albrecht and Eicher, 2001; Bullejos and Koopman, 2001;
Hiramatsu et al., 2009). During this short period, SF1/SRY upregulates
the Sox9 gene by binding to TESCO (testis speciﬁc enhancer core)
upstream of the Sox9 promoter (Sekido and Lovell-Badge, 2008).
In human, SOX9 mutations are responsible for the congenital
disorder campomelic dysplasia, a syndrome characterized by skeletal
malformations, absence of olfactory bulbs and tracts, heart and kidney
disorders and mental retardation. Up to two-thirds of XY patients
exhibit a range of genital defects andoften complete sex reversal (Foster
et al., 1994). Moreover, female-to-male sex reversal has been found in
an XX patient with a duplication of SOX9 (Huang et al., 1999). Mouse
models have shown that Sox9 is required and sufﬁcient to induce testis
development (Barrionuevo et al., 2006; Chaboissier et al., 2004; Vidal et
al., 2001). SOX9 induces Sertoli cell differentiation, the supporting cell
lineage of spermatogenesis. At a molecular level, expression of Sox9
triggers upregulation of a variety of genes involved in male sexual
development, including the direct targets Amh (Arango et al., 1999;
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genes that are known to be critical for male development such as Fgf9
(Kim et al., 2006).
From E12.5, the testicular environment inﬂuences germ cells to
become gonocytes (Best et al., 2008; McLaren and Southee, 1997). In
XY gonads, proliferation of primordial germ cells is followed by their
blockage in G0/G1 phase at E14.5 (Western et al., 2008) and these
gonocytes will remain quiescent until after birth when spermatogen-
esis commences. In XX gonads, the germ cells enter meiosis from
E13.5 and become blocked in prophase I around birth. Follicular cells
then organize around the oocyte, a process driven by the expression of
the transcription factor Foxl2 (Schmidt et al., 2004; Uda et al., 2004).
Thus, sex determination results from the initial switch of either the
testis differentiating pathway or the ovarian determining molecular
cascade in an exclusive manner (Kim et al., 2006). However, both
pathways can be activated in the same gonad resulting in the
development of ovotestes. The vast majority of these organs exhibit a
central testicular region ﬂanked by one or two polar ovarian tissues
(Eicher and Washburn, 2001). Ovotestis differentiation results from
defects in XY gonad differentiation. This can be caused by a low or
delayed expression of the Sry gene in XY gonads (Buaas et al., 2009;
Bullejos and Koopman, 2005). XY ovotestes have been also described
in conditional Fgfr2 mutants (Bagheri-Fam et al., 2008; Kim et al.,
2007). In this case, it has been suggested that the poles of the XY
gonadsmight bemore sensitive to loss of a paracrine signal. FGFR2 is a
receptor of FGF9 and recent data show the requirement of FGF9 to
mediate the formation of sex cords from the center to the poles of the
XY gonads (Hiramatsu et al., 2010).
We have previously generated the transgenic mouse line Wt1:
Sox9Tg/+, in which ectopic expression of Sox9 results in the
development of XX Wt1:Sox9Tg/+ sterile adult males (Vidal et al.,
2001). In this study, we have performed a detailed phenotypic and
molecular analysis of this transgenic line. We show that in XX gonads,
transgenic Sox9 is expressed earlier than endogenous Sox9 in XYwild-
type testis and transgenic Sox9 can activate endogenous Sox9. XXWt1:
Sox9Tg/+ gonads differentiate as ovotestis with a central testicular
region. Strikingly, XX germ cells in the testis parts do not proliferate
but differentiate like XY gonocytes. This indicates that proliferation
and sexual differentiation of XX fetal germ cells are independent, with
the proliferation depending on their sex chromosome constitution
and differentiation being controlled by the somatic environment.
During late embryogenesis, the ovarian regions of XX Wt1:Sox9Tg/+
gonads undergo apoptosis thus leading to a complete sex reversal in
transgenic adults.
Materials and methods
Genotyping of embryos and mice
The experiments herein described were carried out in compliance
with the relevant institutional and French animal welfare laws,
guidelines and policies. All mouse lines were kept on a mixed 129/
C57BL6/J background. The number of tail somite (Ts) was determined
by counting them from the end of the tail until the middle of hind
limb. This corresponds to 2 Ts more than when counting them until
the posterior to the hind limb. The presence of the Y chromosomewas
determined using primers Zfy5′ (5′-GACTAGACATGTCTTAA-
CATCTGTCC-3′) and Zfy3′ (5′-CCTATTGCATGGACTGCAGCTTATG-3′).
Wt1:Sox9 transgene, Sox9–EGFP knock in and Foxl2lacZ were identiﬁed
as published previously (Vidal et al., 2001; Nel-Themaat et al., 2009;
and Schmidt et al., 2004, respectively). Axin2+/LacZ transgenic mice
were generated by Lustig et al. (2002) and genotyped using forward
Axin2 primer 5′-AAGCTGCGTCGGATACTTGAGA-3′, reverse Axin2
primer 5′-AGTCCATCTTCATTCCGCCTAGC-3′ and reverse LacZ primer
5′-TGGTAATGCTGCAGTGGCTTG-3′ (sequences kindly provided by
Michel V. Hadjihannas).Histological and immunological analyses
Embryonic samples from timed matings (day of vaginal plug E0.5)
were collected, ﬁxed in 4% paraformaldehyde overnight at 4°C,
followed by parafﬁn embedding. Microtome sections of 5-μm
thickness were stained with HE according to standard procedures.
Immunoﬂuorescence analysis was performed after antigene retrieval
in 10 mM Na citrate (pH 6) for 2 min in a pressure cooker. Sections
were incubated for 60 min in blocking solution (3% BSA, 10% donkey
serum, 0.1% Triton) at room temperature. Blocking solution was
replaced by a solution of primary antibodies prepared in 3% BSA, 3%
donkey serum, 0.1% Triton at the following concentrations: SOX9
(1:1000) (Stolt et al., 2003, 2005), AMH (C-20: sc-6886, Santa-Cruz,
1:100), DDX4/MVH (ab13840, Abcam, 1:200), FGF9 (PA0152, Cell
Sciences, 1:400), FOXL2 (ab5096, Abcam, 1:100). Relevant Cy3- or
FITC-conjugated anti-rabbit or anti-goat antibodies (1:150, Jackson
Laboratories) were used for detection of primary antibodies. Slides
were mounted using vectashield with a Leica microscope DMLB, and
pictures were taken with a spot RT-slider camera (Diagnostic
instruments) and processed with Adobe Photoshop.
RT-PCR using the LightCycler™ system and TaqMan probe system
Embryonic gonadswere collected at E12.5, immediately snap frozen
in dry ice and stored at −80°C. RNA was extracted using the RNeasy
mini kit (cat. No. 7404, QIAGEN GmbH, D-40725 Hilden, Germany)
according to the manufacturer's instructions. cDNA synthesis was
performed as previously described (Chassot et al., 2008). Primers and
probes were designed by the Roche Assay design center (https://www.
roche-applied-science.com/sis/rtpcr/upl/adc.jsp): Sox9 (NM_011448.4)
5′-cagcaagactctgggcaag-3′ and 5′-tccacgaagggtctcttctc-3′ (probe 66),
Fgf9 (NM_013518.3) 5′- tgcaggactggatttcatttag-3′ and 5′-ccaggcc-
cactgctatactg-3′ (probe 60), Pdgs (NM_008963.1) 5′-ggctcctggacacta-
caccta-3′ and 5′-atagttggcctccaccactg-3′ (probe 89). Real-time PCR
assays were performed on three embryos (n=6 gonads) of each
genotype and compared to standards. Hprt1 (NM_013556.2) 5′-
tcctcctcagaccgctttt-3′ and 5′-cctggttcatcatcgctaatc-3′ (probe 95) primer
and probe set were used to normalize the quantitative real-time PCR
assays for Sox9, Fgf9 and Pdgs. Statistical analysis was performed using
the Prism Graphpad software.
In situ hybridization
In situ hybridizations on paraformaldehyde-ﬁxed/parafﬁn-embedded
sections or on whole-mount embryos were carried out essentially as
described inChassot et al. (2008) andParmaet al. (2006). Sox9 riboprobes
were synthesized according toMorais da Silva et al. (1996). The plasmids
used to synthesize Rspo1, Nanos2, Cyp26b1 and Stra8 digoxigenin
riboprobes were provided by Parma et al. (2006); Chassot et al.
(unpublished data), and Peter Koopman and David Page, respectively.
Whole-mount X-Gal staining and ﬂuorescent imaging
X-Gal staining was performed according to Moore et al. (1998).
SOX9–GFP gonads were dissected and ﬂuorescent signal were
analyzed directly with a Leica microscope MZFLIII.
Counting of germ cells and proliferation
Urogenital organs were dissected, ﬁxed in 4% paraformaldehyde
overnight and processed to obtain 5-mm parafﬁn sections as described
above. For each genotype, 4 sections of at least 3 embryos (6 gonads per
genotype) were processed for immunohistological experiments. DDX4/
MVH antibody was used to identify germ cells and AMH antibody to
determine testis versus ovarian parts. Total germ cells proliferating (both
BrdU- and MVH-positive cells) were quantiﬁed within a predeﬁned
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square area was the same to count germ cells either in ovarian and
testicular regionsof theXX transgenicovotestes andalso inXYorXXwild-
type gonads. Then for each genotype, themean and standard deviation of
thesepercentageswere calculated and reportedonagraphafter statistical
analysis. The results were analyzed using Sigma plot and Graphpad for
statistical relevance.
Germ cell proliferation analysis was performed on the same
embryos using the 5-bromo-2′-deoxy-uridine (BrdU) labeling and
detection kit (Roche). This entailed injecting BrdU into pregnant
females 4 h before collecting the fetal gonads. Total germ cells and
proliferating germ cells (both BrdU- and MVH-positive cells) per
predeﬁned square area were counted on testis, ovarian parts, and
controls using a Zeiss microscope Imager.Z1. For all gonads, the
percentage of BrdU-positive germ cells versus total germ cells was
determined. The results were analyzed using Sigma plot and
Graphpad for statistical relevance.
Apoptosis analysis was performed with the In Situ Cell Death
Detection kit, TMR red (cat. 11 684 795 910, Roche). Apoptotic
(TUNEL-positive cells) were quantiﬁed on the entire section (4
sections of 6 gonads per genotype). Statistical analyses were
performed as described above.Fig. 1. (A) Early expression of Sox9/SOX9 in XXWt1:Sox9Tg/+ gonads. Whole-mount in situ hyb
Sox9 is expressed at a low level in XY (a) and XX (b) control gonads and mesonephros and is u
detected in the central and anterior regions of XY gonads (d) and is expressed in the entire XXW
gonads (i). No expression is observed inXXgonads (e, h). Ts: tail somites. A: anterior pole, P: pos
andE12.5 (m–o). AtE11.5, somecells shownuclear SOX9 inXYgonads (j and inset),whereas the
SOX9 is expressed in XY (m) and XXWt1:Sox9Tg/+ gonads (o). SOX9 is not synthetized in XX
(B) Early function ofWt1:Sox9 transgene. Immunostainings against AMH, a direct target of SOX
gonads show AMH-positive cells (c and white arrowheads) (magniﬁcation ×40). DAPI (blue)Results
Ectopic SOX9 in Wt1:Sox9Tg/+ XX gonads is functional at early stages of
gonadal development
Wt1 is required for gonad formation (Kreidberg et al., 1993) and is
expressed in all somatic cells of the bipotential gonad from the
beginning of its formation at E9.5 (Pelletier et al., 1991). TheWt1:Sox9
transgene places Sox9 expression under the control ofWt1 regulatory
regions suggesting that Sox9 expression might start earlier in XX Wt1:
Sox9Tg/+ gonads than in XY wild-type gonads. At E11 (ts14–16), low
levels of Sox9 expression were detected in wild-type XX and XY
gonads (Fig. 1Aa, b). In contrast, a robust staining was present in the
XX Wt1:Sox9Tg/+ gonads indicating premature upregulation of Sox9
(Fig. 1Ac). At E11.5, whereas Sox9 mRNA was mostly present in the
central region of XY gonads, transgenic Sox9 expression could be
detected throughout the XX Wt1:Sox9Tg/+ gonads (Fig. 1Ad–f). This
indicates that the central to poles gradient of Sox9 expression in the
XY gonad does not occur in XX transgenic gonads. This is likely caused
by the different regulatory elements controlling Sox9 expression in
both cases, i.e., Sox9 elements in XY gonads and Wt1 elements in XX
Wt1:Sox9Tg/+ gonads. At E11.5, immunostaining showed SOX9ridizations using a Sox9 antisense probe at E11 (a–c)–E11.5 (d–f) and E12.5 (g–i). At E11,
pregulated in XXWt1:Sox9Tg/+ gonads and mesonephros (c). At E11.5, Sox9 expression is
t1:Sox9Tg/+ gonads (f). At E12.5, Sox9 expression is similar in XY (g) and XXWt1:Sox9Tg/+
terior pole. Immunodetection of SOX9 inXY, XX andXXWt1:Sox9Tg/+ gonads at E11.5 (j–l)
signal seemspredominantly cytoplasmic inXXWt1:Sox9Tg/+gonads (l and inset).AtE12.5,
gonads (k, n). DAPI (blue) was used to detect nuclei. Posterior poles are on the right side.
9. At E12, XY (a) and XX (b) controls are negative for AMH (red), while XXWt1:Sox9Tg/+
was used to detect nuclei.
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Wt1:Sox9Tg/+ gonads, SOX9 protein was mostly detected in the
cytoplasm. By E12.5, the pattern of Sox9 expression was similar in XX
Wt1:Sox9Tg/+ gonads and XY controls (Fig. 1Ag–i). QPCR experiments
indicated that the level of Sox9 expressionwas higher in XX transgenic
gonads in comparison to XY controls (Fig. 2Ca). At this stage, nuclear
SOX9 was robustly detected in both XX Wt1:Sox9Tg/+ gonads and XY
gonads (Fig. 1Am–o).
Since we detected strong Sox9 expression in XX Wt1:Sox9Tg/+
gonads at an earlier stage than in XY gonads, we next asked whether
transgenic Sox9 in XX gonads is functional at early stages of gonadal
development. To test this, we studied the expression of AMH, a direct
target of SOX9 (De Santa Barbara et al., 1998). Immunostaining
experiments showed that AMH was synthesized in XX Wt1:Sox9Tg/+
gonads at E12 (ts23–26) (Fig. 1B). At ts22–24, AMH was not detected
in XY littermate gonads. These data show that transgenic SOX9 is able
to activate AMH in XX gonads from E12.
Wt1:Sox9Tg/+ activates endogenous Sox9 in XX gonads
SF1 and SRY synergistic binding to TESCO is sufﬁcient for the
gonadal expression of SOX9 (Sekido and Lovell-Badge, 2008). Once
SOX9 is activated, maintenance of its expression is critical to promote
testis differentiation (Kim et al., 2006). However, at E12.5, SRY
expression ceases and in vitro experiments suggest that SOX9 could
maintain its own expression in vivo (Sekido and Lovell-Badge, 2008).
This can be tested in Wt1:Sox9Tg/+ animals by studying whether
transgenic SOX9 can activate the endogenous Sox9 gene. For this, we
employed the Sox9–EGFP knock-in mouse line (Nel-Themaat et al.,
2009). Previous experiments showed that SOX9 and EGFP co-localize
indicating that EGFP follows the expression of SOX9 (Nel-Themaat et
al., 2009).
At E11.5, XY Sox9–EGFP testis exhibited green ﬂuorescence and no
EGFP signal was visualized in XX Wt1:Sox9Tg/+; Sox9–EGFP and XX
Sox9–EGFP gonads (Fig. 2Aa–c). At E12.5, green ﬂuorescence was
observed in XX Wt1:Sox9Tg/+; Sox9–EGFP gonads, but the intensity of
the ﬂuorescence was lower than in XY Sox9–EGFP testis (Fig. 2Ad–f).
By E13.5, green ﬂuorescing sex cords were observed in both XY Wt1:
Sox9Tg/+; Sox9–EGFP and XX Wt1:Sox9Tg/+; Sox9–EGFP, but not in XX
Sox9–EGFP gonads (Fig. 2Ag–i). Taken together, these results show
that SOX9 can initiate and maintain its own expression, but activation
of Sox9–EGFP is less efﬁcient and delayed when compared to XY
control gonads. At E12.5, this delay of endogenous Sox9 activation is
not due to a lack of SOX9 expression, since overall expression of SOX9
(transgenic and endogenous) was comparable in XXWt1:Sox9Tg/+ and
XY wild-type gonads at E12.5 (Fig. 1Am–o).
Whereas initially Sox9 expression requires SRY for its activation in
XY gonads, the two independent downstream signaling pathways
FGF9/FGFR2 and PGD2/PGDS are involved in its maintenance (Kim et
al., 2006; Moniot et al., 2009). To test whether these pathways were
upregulated in XX Wt1:Sox9Tg/+ gonads, we performed QPCR and in
situ hybridization experiments with a probe for Pgds. At E12, Pgdswas
expressed in XX Wt1:Sox9Tg/+ gonads. However, the signal appeared
stronger in XY controls at this stage (Fig. 2Bd–f). By E12.5, QPCR
analysis showed no signiﬁcant difference in Pdgs expression between
XY gonads and XX Wt1:Sox9Tg/+ gonads (Fig. 2Cc). In addition, the
level of Pgds hybridization signal was shown to be similar on XY andFig. 2. (A) Regulation of SOX9–EGFP byWt1:Sox9 transgene. The green ﬂuorescence of Serto
detected in XXWt1:Sox9Tg/+ gonads (c) compared to XY gonads (a) (magniﬁcation ×5). At E
EGFP gonads (f) (magniﬁcation ×5) and is expressed similarly in XYWt1:Sox9Tg/+; Sox9–EGFP
of SOX9–EGFP is delayed in XXWt1:Sox9Tg/+; Sox9–EGFP gonads compared to XY Sox9–EGFP
pole, A: anterior pole. (B) FGF9 and Pgds are upregulated in XX Wt1:Sox9Tg/+ gonads. Upper
(a) and XX Wt1:Sox9Tg/+ (c) gonads (magniﬁcation ×40) but no in XX gonads (b). DAPI
hybridization on sections using a Pgds antisense probe. At E12 Pgds is expressed at a low l
expressed similarly in XY (g) and XXWt1:Sox9Tg/+ gonads but Pgds expression is restricted to
XX gonads (e, h). P: posterior pole, A: anterior pole. Ts: tail somites. (C) Quantitative RT-PCXXWt1:Sox9Tg/+ gonad sections (Fig. 2Bg–i); however, this signal was
restricted to the central region of the XX Wt1:Sox9Tg/+ gonads. At
E12.5, FGF9 was also expressed at an equivalent level in XY and XX
Wt1:Sox9Tg/+ sex cords (Fig. 2Ba–c and Cb). These results show that
transgenic SOX9 is able to induce upregulation of Pgds and FGF9. Thus,
these two pathways could be involved in the establishment and
maintenance of robust expression of SOX9–EGFP.
Ovotestes formation in XX Wt1:Sox9Tg/+ embryos
While performing the above experiments, it was observed that the
XX Wt1:Sox9Tg/+ gonads exhibit a polar region negative for Pgds
(Fig. 2Bi) or for GFP in XX Wt1:Sox9Tg/+; Sox9–EGFP (Fig. 2Ai). To
better visualize the cellular organization of the XX Wt1:Sox9Tg/+
gonads, we performed histological analyses at E14.5 and E15.5 (data
not shown and Fig. 3A). Similar to XY wild-type gonads, XX Wt1:
Sox9Tg/+ gonads contained testicular cords and gonocytes arrested in
G0/G1 located within these cords (Fig. 3Aa, d and c, f). However, a
region located at the poles of transgenic gonads did not contain
testicular cords, but instead meiotic germ cells reminiscent of XX
control ovaries (Fig. 3Ab, e and c, g). In most of the histological
sections, some condensed nuclei reminiscent of apoptotic ﬁgures
were also present in ovarian regions of the XX transgenic gonads
(Fig. 3Ag) (see further).
To determine the identity of this polar region, we studied the
expression of two genes speciﬁcally upregulated in early ovarian
differentiation, Foxl2 and Rspo1 (Parma et al., 2006; Schmidt et al.,
2004). To detect Foxl2 expression, we made use of a previously
generated Foxl2:LacZ knock-in allele and control ovaries showed
strong staining throughout the gonad. β-Galactosidase staining in XX
Wt1:Sox9Tg/+; Foxl2+/LacZ embryos at E13.5 and E15.5 showed that
while the central region was devoid of staining, one or both poles of
the gonads expressed Foxl2+/LacZ (Fig. 3Ba–f). Similarly, Rspo1 in situ
hybridizations on E13.5 sections of XY, XX and XX Wt1:Sox9Tg/+
gonads showed that Rspo1 was expressed not only in XX controls but
also at the poles of the XX Wt1:Sox9Tg/+ gonads (Fig. 3Bg–i). Taken
together these results suggest that ectopic expression of Sox9 can lead
to the formation of an ovotestis in XX gonads during the fetal period.
Post-transcriptional regulation of Sox9 in ovarian cells of the ovotestis
To study whether FOXL2 and SOX9 are expressed in a mutually
exclusive manner, immunostainings were performed using XY, XX
controls and XX Wt1:Sox9Tg/+ ovotestes. At E14.5 FOXL2 was
expressed in the ovarian regions of the XX Wt1:Sox9Tg/+ gonads and
in the XX controls, whereas SOX9 was detected in the testicular
regions of the XY and Wt1:Sox9Tg/+ gonads (Fig. 4Aa–c). However,
closer examination and longer immunostaining showed faint staining
of nuclear SOX9 also in ovarian regions of XX Wt1:Sox9Tg/+ gonads
(Fig. 4Ba–d).
A potential reduction of Sox9 expression in the ovarian regions
seems surprising given that the Wt1 regulatory region is expected to
drive expression in both XY and XX gonads. We therefore studied
whether Sox9 is transcribed in the whole gonads of XX Wt1:Sox9Tg/+
ovotestes at E13.5. Whole-mount in situ hybridizations using a Sox9
probe conﬁrmed that Sox9 is expressed along the entire length of the
gonad inXXWt1:Sox9Tg/+ fetuses, as previously shown (Fig. 4Be–g–1A).li cells is synthetized from SOX9–EGFP (a to i). At E11.5, green ﬂuorescent cells are not
12.5, SOX9–EGFP is weakly expressed in XXWt1:Sox9Tg/+ (f) in comparison to XY Sox9–
(g) and XXWt1:Sox9Tg/+; Sox9–EGFP (i) gonads at E13.5, indicating that the expression
gonads at E12.5. SOX9–GFP is not detected in XX Sox9–EGFP (b, e, h) gonads. P: posterior
panel: immunodetection of FGF9 in gonads at E12.5. FGF9 is robustly expressed in XY
(blue) was used to detect nuclei. Middle and lower panels: whole-mount and in situ
evel in XX Wt1:Sox9Tg/+ gonads (f) in comparison to XY gonads (d). At E12.5, Pgds is
the anterior and central parts of theWt1:Sox9Tg/+ gonad. No expression was detected in
R analysis of Sox9, Fgf9 and Pgds. For each genotype, n=6 gonads were used.
Fig. 3.Ovotestis development in XXWt1:Sox9Tg/+ gonads. (A) Hematoxylin and eosin stainings of E15.5 embryos gonadal sections (magniﬁcation ×10 and ×100). In XXWt1:Sox9Tg/+
gonads (c, f, g), the anterior region contains testis cords with G0/G1 quiescent gonocytes (c, f) (blue arrowheads) like in XY gonads (a, d). The posterior region of XXWt1:Sox9Tg/+
gonads contains meiotic germ cells (c, g) like XX gonads (b, e) (pink arrowheads) and apoptotic cells (g) (black arrowhead). Male and female symbols in f and g indicate the
testicular or ovarian tissues of the transgenic gonads. (B) Poles of XXWt1:Sox9Tg/+ gonads develop as ovarian tissue. Upper panel: X-Gal whole-mount staining at E13.5 (a, c, e) and
E15.5 (b, d, f). Strong blue staining is representative of Foxl2–LacZ expression. Blue staining is detected in XX Foxl2+/LacZ gonads (c, d) indicating ovarian differentiation in the anterior
and posterior regions (e) and in the posterior region (f) of XX Wt1:Sox9Tg/+; Foxl2+/LacZ gonads (Arrows). This shows that ovarian poles are present in XX transgenic gonads. XY
gonads are devoid of staining (a, b). The posterior poles are the lower poles. Lower panel: in situ hybridizations on sections with Rspo1 probe (g, h, i) conﬁrm that XXWt1:Sox9Tg/+
gonads contain ovarian tissues.
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expression of the transgenic and the endogenous Sox9 gene. Indeed, in
situ hybridizations on XXWt1:Sox9Tg/+; Sox9–EGFP sections with a Gfp
probe reveal a strong staining of Gfp in testicular cords likelymimicking
endogenous Sox9 expression (Fig. 4Bh–j). These results suggest that
Sox9 transcription in ovarian cells is not sufﬁcient to induce/maintain
sex reversal after E13.5.
In XY gonads, ectopic activation of the Wnt/β-catenin pathway
results in male-to-female sex reversal (Maatouk et al., 2008) by
disrupting the maintenance of the testis-determining pathway
(Chang et al., 2008). Interestingly, in vitro data show that β-catenin
can interact with SOX9 to induce its degradation (Akiyama et al.,
2004). To test whether β-catenin stabilization may be involved in
feminization of the poles in the Wt1:Sox9Tg/+ gonad, we made use of
the Axin2:LacZ strain, a universal reporter of β-catenin stabilization
(Lustig et al., 2002). Indeed, β-catenin was stabilized in the ovarian
regions of XX Wt1:Sox9Tg/+ ovotestes (Fig. 4C). This suggests that
failure of SOX9 accumulation in ovarian areas of the transgenic gonads
may be caused by activation of β-catenin, which in turn may inhibit
SOX9 by a post-transcriptional mechanism.
Germ cell proliferation is controlled by their sex chromosome
constitution in XX Wt1:Sox9Tg/+ gonads
Germ cells proliferate until E12.5 and E14.5 in XX and XY gonads,
respectively (Western et al., 2008). In XXY testes, germ cells undergodegeneration when spermatogenesis initiates after birth (Hunt et al.,
1998). However, double immunostainings for AMH and MVH (germ
cell marker) showed that less germ cells were present in the testicular
region of the transgenic ovotestes as early as E14.5 (Fig. 5A). To
determine whether germ cell numbers may be affected in our
transgenic model, we counted germ cells at E12.5, E13.5 and E14.5
in XY and XXWt1:Sox9Tg/+ gonads. At E12.5, there was no signiﬁcant
difference between the number of germ cells in both genotypes
(Fig. 5Ba, blue histograms), but at E13.5 and E14.5, we found a
dramatic reduction in the testicular region of XX transgenic compared
to XY wild-type gonads (Fig. 5Bb, c, blue histograms). At E14.5, the
numbers of germ cells between control ovaries and the ovarian region
of XXWt1:Sox9Tg/+ ovotestes were similar (Fig. 5Bd, pink histograms),
but less germ cells were observed in the testicular compared to the
ovarian regions in the transgenic gonads (Fig. 5Be, pink histograms).
Low numbers of germ cells in testicular regions of XX transgenic
embryos were not linked to germ cell apoptosis at E12.5 (data not
shown) or E14.5 (Fig. 7B). Thus, we speculated that germ cell pro-
liferation might be impaired in testicular regions of XX Wt1:Sox9Tg/+
gonads. To check this hypothesis, we performed BrdU incorporation
experiments at E12.5 and E13.5. At E12.5, the numbers of BrdU-
positive germ cells were equivalent in XX transgenic gonads and XY
controls (Fig. 5Ca, b, e), whereas the number of BrdU-positive germ
cells was reduced in XXWt1:Sox9Tg/+ gonads compared to XY gonads
(Fig. 5Cc, d, f). Taken together, these results show that XX germ cell
proliferation is impaired in testicular regions of the transgenic gonads.
Fig. 4. Sox9 post-transcriptional regulation in XXWt1:Sox9Tg/+ gonads. (A) Immunodetection of SOX9 (red) and FOXL2 (green) in E14.5 gonads (magniﬁcation ×20). Whereas SOX9
is strongly expressed in XY gonads (a) and FOXL2 in XX gonads (b), both proteins are detected in XX Wt1:Sox9Tg/+ gonads (c) but seem not to be expressed in the same cells.
Posterior poles are on the right side. DAPI (blue) was used to detect nuclei. (B) Upper panel: high magniﬁcation (×100) of XXWt1:Sox9Tg/+ gonads shows low level of nuclear SOX9
in ovarian parts (d) compared to high level of SOX9 expression in testicular regions (c) or in XY gonads (a). Middle panel: whole-mount in situ hybridizations of Sox9 at E13.5 in XY
(e), XX (f) and XX transgenic gonads (g). The blue staining corresponds to whole Sox9 expression (transgene plus gene) and shows Sox9 transcription in testicular and ovarian parts
of XX Wt1:Sox9Tg/+ gonads (g) and in XY gonads (e). Male and female symbols in g indicate the testicular or ovarian tissues of the transgenic gonads. Lower panel: in situ
hybridizations on sections of XY (h) and XX SOX9–EGFP (i) and XX Wt1:Sox9Tg/+, SOX9–EGFP gonads (j), using a Gfp probe, indicate that Sox9–Gfp endogenous expression is
restricted to sex cords (h, j). Male and female symbols in j indicate the testicular or ovarian tissues of the transgenic gonads. (C) β-Catenin activity in the XX Wt1:Sox9Tg/+ ovarian
poles. X-Gal (Axin2–LacZ) whole-mount staining of gonads at E13.5 (a–c). Blue staining is representative of Axin2 expression, a gene upregulated after β-catenin activation. The
staining is located in the ovarian region of XX Wt1:Sox9Tg/+; Axin2+/LacZ and in XX Axin2+/LacZ gonads. The posterior poles are the lower ones.
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(Natoli et al., 2004), we did not detect ectopic expression of SOX9 in
germ cells (data not shown), excluding a direct effect of the transgene
in germ cells. These data rather imply that the somatic environment of
XX germ cells does not regulate their proliferation and this is
controlled by their sex chromosome constitution.Germ cells differentiate according to their somatic environment in XX
Wt1:Sox9Tg/+ gonads
It has been shown previously that XX germ cells differentiate
predominantly as gonocytes in XX/XY chimeric testes (Palmer and
Burgoyne, 1991) suggesting that XX germ cells differentiate according
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XX Wt1:Sox9Tg/+ gonads, we performed in situ hybridization experi-
ments using Stra8, a marker of meiotic commitment (Baltus et al.,2006). Wild-type ovaries and ovarian regions of XX Wt1:Sox9Tg/+
ovotestes exhibited staining indicating the presence of meiotic
oocytes (Fig. 6a–c). In contrast, control testes and the testicular
Fig. 6.Germ cells differentiation in XXWt1:Sox9Tg/+ ovotestis depends on their somatic environment. Upper panel: whole-mount in situ hybridizations using Stra8 as a probe at E13.5
(a, b, c) show a strong expression in XX gonads and XXWt1:Sox9Tg/+ ovarian parts indicating meiosis commitment of germ cells. Middle panel and lower panel: whole-mount in situ
hybridizations using Cyp26b1 (d, e, f) andNanos2 (g, h, i) as probes at, respectively, E13.5 and E14.5 showXX gonocytes differentiation in both XXWt1:Sox9Tg/+ testicular regions and
in XY gonads. Note the weak level of Nanos2 expression likely due to low number of germ cells.
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meiotic germ cells were mostly present in the ovarian regions of the
transgenic gonads. Meiotic commitment is controlled by various
stimuli including the retinoic acid (RA) pathway (Bowles et al., 2006;
Koubova et al., 2006). In embryonic testes, low levels of RA are
required for gonocytes to become quiescent (Trautmann et al., 2008).
RA levels are controlled by the activity of the testis-speciﬁc RA
degrading enzyme, CYP26B1. When using Cyp26b1 as a probe, we
found strong expression in the testicular regions of XX Wt1:Sox9Tg/+
ovotestes at levels comparable to those of wild-type testes (Fig. 6d–f).
Thus, the quiescence of XX gonocytes in XX Wt1:Sox9Tg/+ gonads is
likely to be associated with the activity of CYP26B1.
Nanos2 is also a key regulator of XY gonocyte differentiation
(Suzuki and Saga, 2008), and as such, it is speciﬁcally expressed in XY
gonocytes. To determine whether Nanos2 is expressed in the XX
gonocytes located in the sex cords of the XX Wt1:Sox9Tg/+ embryos,
we carried out in situ hybridizations. A robust staining was visualizedFig. 5. Defects of XX germ cell proliferation in XX Wt1:Sox9Tg/+ testicular parts. (A) Immun
(blue) was used to detect nuclei. Germ cells seem to be less abundant in testicular region of X
side. (B) Numbers of germ cells in XX, XY controls (pink and blue histograms, respectively) an
blue histograms, respectively). The values are number of germ cells per square area. At E12.5
gonads) and XY gonads (n=6) (a) whereas at E13.5 and E14.5, germ cells are highly signiﬁ
compared to XY controls (n=7 and 4, respectively) (b, c). At E14.5, whereas no signiﬁcant di
XX transgenic gonads (n=4), germ cells are less abundant in testicular parts compared to ov
gonads and testicular parts of XXWt1:Sox9Tg/+ gonads (blue and striped blue pink histogram
(blue) allowed to identify the sex cords of the testicular regions of XX transgenic gonads (ma
there were signiﬁcantly less BrdU-positive germ cells in XXWt1:Sox9Tg/+ gonads compared t
XY gonads (n=5) and XX Wt1:Sox9Tg/+ ovotestis (n=6).in XY wild-type gonads and a weaker signal, likely to be due to a low
number of germ cells, was detected in XX Wt1:Sox9Tg/+ testicular
regions (Fig. 6g–i).
Taken together, our results show that whereas XX germ cell
proliferation depends on their genotype, germ cells differentiate
according to their somatic environment in XXWt1:Sox9Tg/+ fetus. This
indicates that both mechanisms are independent.Regression of the ovarian regions of XX Wt1:Sox9Tg/+ gonads
Althoughwe have shown that ovarian poles differentiate in XXWt1:
Sox9Tg/+ fetal gonads, we have not observed ovarian tissues in adult
mice and transgenic gonadswere azoospermic testis (Vidal et al., 2001).
At birth, histological analyses conﬁrmed the absence of forming follicles
or meiotic germ cells indicating that XX Wt1:Sox9Tg/+ gonads were
testes (Fig. 7A).odetection of AMH (green) and MVH (red) in E14.5 gonads (magniﬁcation ×20). DAPI
X transgenic gonads (c) compared to XY gonads (a). The posterior poles are on the right
d in ovarian and testicular regions of XXWt1:Sox9Tg/+ gonads (shaded pink and shaded
, no signiﬁcant differences are observed between XXWt1:Sox9Tg/+ ovarian tissues (n=4
cantly less abundant in XX Wt1:Sox9Tg/+ testicular tissues (n=10 and 6, respectively)
fferences are observed between germ cell numbers in XX (n=3) and ovarian regions of
arian parts of XX transgenic gonads (e). (C) Percentages of proliferating germ cells in XY
s, respectively). Immunostainings (a, b, c, d) using anti-BrdU (green), MVH (red), AMH
gniﬁcation ×40). At E12.5 (e), no signiﬁcant difference was observed, whereas at E13.5,
o XY controls (f). At 12.5 XY gonads (n=4), XXWt1:Sox9Tg/+ ovotestis (n=2). At E13.5,
Fig. 7. Regression of ovarian regions in XX Wt1:Sox9Tg/+ ovotestis. (A) Hematoxylin and eosin staining of P0 gonadal sections. XX Wt1:Sox9Tg/+ gonads show no obvious ovarian
parts. (B) TUNEL experiments show higher number of apoptotic cells in the ovarian parts (d) compared to the testicular parts of the XXWt1:Sox9Tg/+ gonads (c) or to XY (a) or XX (b)
control gonads (magniﬁcation ×40). Male and female symbols in c and d indicate the testicular or ovarian tissues of the transgenic gonads. MVH (green). TUNEL (red). DAPI (blue)
was used to detect nuclei. Quantiﬁcation of the number of apoptotic cells in XX Wt1:Sox9Tg/+ ovotestis (n=6) (e) shows that high levels of apoptotic cells are detected in ovarian
parts of the XX transgenic gonads in comparison to the testicular parts. (C) Regression of the ovarian tissues of XXWt1:Sox9Tg/+ gonads between E13.5 and E16.5. XYWt1:Sox9Tg/+;
Axin2+/LacZ or XYWt1:Sox9Tg/+; Foxl2+/LacZ males (mixed background) were mated to C57BL/6 females. X-Gal staining allowed to visualize the ovarian regions in F1 fetal gonads at
E13.5 and E16.5. Tail biopsies were used for genotyping. The gonads were scored according to their morphology (n= number of ovaries, ovotestes with one or two ovarian poles and
testes). The drawing shows the testicular regions containing sex cords. Although each transgenic gonadwas scored, the structural patternwas always similar between both gonads of
the embryo, suggesting no left–right asymmetric effects. At E16.5, no ovotestes were observed in XY Wt1:Sox9Tg/+; Axin2+/LacZ fetus.
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apoptotic cells in the ovarian regions of the ovotestes (Fig. 3Ag).
Moreover, at this stage, the ovarian regions were very small or absent
in most of the transgenic gonads (data not shown). Indeed, TUNEL
experiments conﬁrmed the presence of apoptotic nuclei in the ovarian
regions at E14.5 (Fig. 7Ba–d). Quantiﬁcation of the number of apoptotic
cells in ovarian and testicular regions of the XX Wt1:Sox9Tg/+ ovotestis
showed that there was a signiﬁcant increase of apoptotic cells in the
ovarian regions of theovotestes (Fig. 7Be). This suggests that the ovarian
regions that initially form in XX Wt1:Sox9Tg/+ gonads subsequently
regress by apoptosis.
We next analyzed whether XX Wt1:Sox9Tg/+ gonads are initially
developing as ovotestes and whether speciﬁc regression of the
ovarian regions may be responsible for testis development. For this,we analyzed the morphology of 16 and 14 XXWt1:Sox9Tg/+ gonads at
E13.5 and E16.5, respectively. The ovarian regions were identiﬁed by
X-Gal staining using XXWt1:Sox9Tg/+; Foxl2:LacZ or XXWt1:Sox9Tg/+;
Axin2:LacZ embryos and gonads were scored according to their
structure, i.e., ovary, both ovarian poles, one ovarian pole, no ovarian
tissue (Fig. 7C). At E13.5, 87.5% (14/16) of the gonads showed one or
two ovarian poles and 12.5% (2/16) showed no X-Gal staining
implying that they were fully differentiated as testis. This variability
of the gonadal phenotypes of the XXWt1:Sox9 transgenic fetusmay be
due to the mixed genetic background of this line.
At E16.5, 14.3% (2/14) showed X-Gal staining along the entire
gonads indicating that they were ovaries. Both gonads were from the
same embryo and might be due to an epigenetic silencing of the
transgene. At this stage, 85.7% (12/14) XX transgenic gonads were
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had become eliminated. Taken together, these data suggest that while
XX Wt1:Sox9Tg/+ gonads initially differentiate as ovotestes, speciﬁc
apoptosis within the ovarian portion of the gonad leads to testis
development by E16.5.
Discussion
Genes involved in sexual differentiation are expressed at a low
level in the bipotential gonad (Kim et al., 2006). Activation of either
the testis-determining pathway, with SRY being the main switch in
the XY gonad, or the ovarian differentiating pathway, with Rspo1
activating the Wnt/β-catenin signaling pathway, induces sex
determination.
SOX9 regulation in XX transgenic gonads
In mice, proper testis differentiation is temporally tightly con-
trolled. Sry function is effective between E11.00 and 11.25 with
expression being initiated in the central region and reaching the poles
of the gonads at E11.25 (Hiramatsu et al., 2009). SRY directly activates
Sox9 expression (Sekido and Lovell-Badge, 2008), and FGF9 signals are
required to maintain Sox9 expression and thus allow progression of
sex cord formation from the center to the poles (Hiramatsu et al.,
2010). Our analysis suggests that the overall level of Sox9 transcript is
similar or even higher in XX Wt1:Sox9Tg/+ gonads than in XY gonads.
However, since Sox9 expression is controlled by the Wt1 regulatory
region in XX Wt1:Sox9Tg/+ gonads, its expression is not restricted to
the Sertoli cell lineage. Moreover, at E11.5, cells with nuclear SOX9 are
more abundant in XY gonads than in XX transgenic gonads. Thus it is
likely that in the cells that will eventually differentiate as Sertoli cells
in XX Wt1:Sox9Tg/+ gonads, the level of Sox9 expression per cell is
lower compared to those in Sertoli cells in the XY gonads. We
conclude that the Wt1:Sox9 transgene is not as efﬁcient as Sry to
induce testis development and thus results in ovotestis formation. XX
Wt1:Sox9Tg/+ ovotestes showed a similar organization than XY
ovotestes with testicular cords in the central region and ovarian
tissues at the poles of the gonads (Eicher and Washburn, 2001). In XY
gonads, SRY induces a central to pole wave of Sertoli cell differenti-
ation. Our results show that during sex reversal of XX gonads such
a wave of differentiation also exists despite the fact that the Wt1:
Sox9Tg/+ transgene is evenly expressed throughout the entire XX
gonad. Since the transgene is unable to promote sex cord formation at
the poles, this promotes an opposite wavelike ovarian differen-
tiation from the poles to the center. Thus, the overall lower cellular
expression of Sox9 from the transgene appears to be insufﬁcient to
prevent ovarian differentiation.
Whereas early expression of Sox9 is induced by SRY in XY gonads,
Sox9 remains expressed at E12.5when SRY expression has ceased. SRY
and SOX9 belong to the same family of genes, the SOX genes (Wegner,
1999), and has been suggested that they may serve similar functions
during testis formation. For instance, transgenic SRY, SOX9 and SOX10
are able to induce female-to-male sex reversal (Koopman et al., 1991;
Polanco et al., 2010; Vidal et al., 2001; and the present data). Thus
SOX9 could take over SRY function and promote its own expression at
E12.5. We have shown here that in XX Wt1:Sox9Tg/+; Sox9–EGFP
gonads, the Sox9 transgene can induce the expression of EGFP
knocked into the Sox9 locus implying that SOX9 can activate its own
expression. Earlier ChIP experiments (Sekido and Lovell-Badge, 2008)
showed that SRY immuno-precipitated fragments in TESCO were
different from that precipitated by SOX9 antibodies, a sequence also
pulled down with SF1. This suggests that Sox9 regulation by SRY is
mechanistically different from a potential autoregulation of SOX9.
WhereasWt1:Sox9 is robustly expressed (at the level of transcript and
protein) at E12.5, it fails to upregulate efﬁciently Sox9–EGFP at thisstage. Taken together these data suggest that SOX9 might not directly
regulate its own expression in XX Wt1:Sox9Tg/+ gonads.
In mice, mutations in Rspo1 or Wnt4, two genes of the ovarian
differentiation pathway, trigger sex reversal of XX embryonic gonads
and Sox9 becomes upregulated in these tissues (Chassot et al., 2008;
Vainio et al., 1999). Sox9 upregulation can also be achieved by grafting
embryonic ovaries under the kidney capsule. In this case, a reporter of
TESCO expression (TESCO-CFP) becomes weakly expressed 10 days
after the grafts, and high levels of CFP are detected 30 days post-grafts
(Sekido and Lovell-Badge, 2008). How SOX9 becomes activated
without the presence of SRY is presently unknown. A potential
mechanism could involve the FGF9/FGFR2 and PDG2/PGDS signaling
pathways, both of which are required for SOX9 maintenance (Kim
et al., 2006; Moniot et al., 2009). The delayed onset of endogenous
Sox9 expression in XX Wt1:Sox9Tg/+ gonads suggests that SOX9 by
itself is insufﬁcient to induce its own expression. By contrast, forced
expression of SOX9 induces robust upregulation of Pgds and FGF9 at
E12.5, which is likely to contribute to the induction of Sox9–EGFP
expression. Since FGFR2 has been detected in the nucleus of Sertoli
cells (Schmahl et al., 2004), it is conceivable that nuclear FGFR2 may
directly contribute to Sox9 activation.
Regression of ovarian regions leads to full testis development in XX Wt1:
Sox9Tg/+ mice
Ectopic expression of SOX9 in XX gonads triggers full sex reversal of
adultmice. This can be achieved either by transgenesis (Vidal et al., 2001)
or caused by mutations in the upstream region that lead to activation of
the endogenous Sox9 gene (Bishop et al., 2000). Thus, it is surprising that
before full sex reversal becomes apparent, there is an embryonic period
(E13.5–E16.5) when XX Wt1:Sox9Tg/+ gonads develop as ovotestes. At
E13.5, theovarian regionsarevariable, i.e., theyarepresent either atoneor
both poles of the XX transgenic gonads or are absent. This indicates that
theWt1:Sox9 transgeneefﬁciency is variable and this is likely associated to
variability of the XX background (Munger et al., 2009) resulting in
incomplete penetrance of sex reversal. Sox9 expression from the
transgene occurs at E11 and persists in the entire gonad at E11.5–12.5
and E13.5 (Vidal et al., 2001, and present results). Although, Sox9
transcripts are evenly expressed in the transgenic gonads, the protein
does not accumulate in the ovarian poles of the transgenic ovotestis and
thus leads to ovarian differentiation. In wild-type testis Fgf9 signaling
plays an important role in the maintenance of Sox9 expression, which
involves the control at the level of transcription (Kim et al., 2006). InWt1:
Sox9 mice, the Sox9 transgene is not regulated by its own promoter and
thus is maintained throughout the gonad. The fact that we could not
detect SOX9proteinat thepolesdespite thepersistenceofRNAexpression
may suggest that post-transcriptional regulation is also involved in
preventing SOX9 accumulation. Stabilization of β-catenin is required for
ovarian differentiation (Chassot et al., 2008). Ectopic β-catenin activation
in XY gonads prevents testicular development (Maatouk et al., 2008) and
suppression of β-catenin signaling is essential for proper testis formation
(Changet al., 2008). In vivo, SOX9preventsβ-cateninaccumulationduring
cartilage differentiation, as well as within the intestinal epithelium
(Akiyama et al., 2004; Bastide et al., 2007). It is possible that a similar
mechanism of SOX9 degradation promotes ovarian cell maintenance
during normal differentiation and that initial stabilization of β-catenin
leads to SOX9 protein degradation at the poles of XX Wt1:Sox9Tg/+
ovotestes. However, the ovarian poles in XXWt1:Sox9Tg/+ gonads seem to
be transiently present. At E13.5, 87.5% of XX Wt1:Sox9Tg/+ gonads are
ovotestes and 85.7% are testes at E16.5. Apoptosis of the ovarian regions
occurs at E14.5, indicating ovarian pole regression in XX embryonicWt1:
Sox9Tg/+ ovotestes. Interestingly, the apoptotic cells detected in this
analysis were somatic cells. This has not be described in XY ovotestes
(Eicher andWashburn, 2001), suggesting that theantagonismbetweenβ-
catenin and continual expression of Sox9 cause somatic cells to undergo
apoptosis. Although we did not detect germ cell apoptosis at E14.5 in
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degeneration at birth in XXY testis (Hunt et al., 1998). This suggests that
degeneration could also occur in XXWt1:Sox9Tg/+ testes. Indeed, we did
not observe germ cells in adult transgenic animals (Vidal et al., 2001).
XX germ cell proliferation is uncoupled from their differentiation in XX
Wt1:Sox9Tg/+ ovotestes
Previous data showed that the RNA helicaseMVH is expressed in XX
and XY germ cells but is only required for germ cell proliferation in
embryonic testis (Tanaka et al., 2000) indicating that germ cell
proliferation depends on different signals in XX and XY gonads. In
testicular regions of the XXWt1:Sox9Tg/+ gonads, germ cell proliferation
is lower than in XY controls. Moreover, the number of germ cells in
testicular parts of XX transgenic ovotestis is lower than in the ovarian
parts, suggesting that XX germ cells in testicular regions fail to
proliferate as efﬁciently as in ovarian tissues. Thus XX germ cells are
not fully competent to respond to proliferative stimulating signals from
the testicular somatic environment suggesting that the proliferation of
germ cells in fetal testis depends at least in parts on their genotype.
Transgenic experiments have shown that Eif2s3y transgenes rescue
the spermatogonial proliferation failure of mutants bearing a chromo-
somal deletion of the Y chromosome. Thus genes on the Y chromosome
are essential for spermatogenesis (Mazeyrat et al., 2001). Our results
suggest that some Y factorsmay also be required for pro-spermatogonia
proliferation. Whether these genes are the same as those involved for
proliferation at beginning of spermatogenesis remain to be elucidated.
In XX/XY chimeric gonads or XX Wt1:Sox9Tg/+ gonads, XX germ
cells adopt the fate of their environment, i.e., become oogonia in
ovarian regions and pro-spermatogonia in testicular regions of the
ovotestes (Palmer and Burgoyne, 1991, and present results). Whereas
FGF9 is required for germ cell survival and differentiation in XY
gonads, it is not involved in their proliferation (Barrios et al., 2010)
(DiNapoli et al., 2006). Thus these data suggest that germ cell
proliferation and differentiation are two independent mechanisms.
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